About
- About Avecho
- Board & Leadership
TPM^® Technology
Portfolio
Invest
- Investor Centre
- Media Centre
Contact

Hit enter to search or ESC to close

Phosphagenics Announces Transition of Chairman of Board

April 21, 2017

Click here to read more

Post navigation

Phosphagenics Participation in ‘New Innovations in Drug Delivery Technology’ Webcast

Phosphagenics Notice of Annual General Meeting

Related Posts

Extension of Closing Date of Entitlement Offer

October 10, 2017

Ethics Approval for amendments to Phase III Clinical Trial

March 7, 2024March 7, 2024

Media Coverage | Nine News

October 21, 2024October 21, 2024

Recent Posts

Media Coverage | Nine News
October 21, 2024
First Patient Dosed in Phase III Insomnia Trial
May 16, 2024
MEDIA | Channel 9 News
March 28, 2024

Categories

Analyst Coverage
Company Announcement
Company Report
Media Coverage
Newsletter
Press Release
Uncategorised

About us

We see a future where more patients can get even more from their treatments through innovative delivery technologies.

Stay Posted

Stay informed about our latest news and developments.

Leave this field empty if you're human:

About Avecho

TPM^® Technology

Portfolio

Investor Centre
- Investor Centre
- Media Centre

© Copyright 2019 Avecho Biotechnology Ltd.